What is the role of oxygen in FLASH radiotherapy using electron beams?
Abstract
Objective: To evaluate the role of oxygen in the FLASH effect during electron beam radiotherapy, aiming to understand mechanisms that enable normal tissue sparing at ultra-high dose rates.
Methods: A systematic literature review was conducted, analyzing 27 studies involving mathematical models and experimental approaches (in silico, in vitro, ex vivo, and in vivo) related to the use of electron beams in FLASH radiotherapy.
Results: The studies indicate that optimal normal tissue sparing occurs at oxygen concentrations up to 7 % during irradiation at dose rates ≥ 40 Gy/s. The FLASH effect is associated with partial oxygen depletion, radical-radical recombination, modulation of apoptosis and post-irradiation repopulation, and varying antioxidant responses between normal and tumor tissues.
Significance and conclusion: Understanding oxygen's role is crucial for optimizing FLASH protocols, especially in electron beam applications. These findings support the development of radiotherapy strategies that minimize normal tissue toxicity while maintaining tumor control. The FLASH effect is likely governed by a combination of beam physics and biological factors, particularly oxygen availability and oxidative stress balance. This equilibrium influences DNA damage and cellular recovery, making oxygen a key modulator of the FLASH response.
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in cell cultures (in vitro), not in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Preliminary Toxicity Analysis of 3DCRT versus IMRT on the High Dose Arm of the RTOG 0126 Prostate Cancer Trial
- Adaptive Radiotherapy for Head and Neck Cancer: Initial Clinical Outcomes from a Prospective Trial
- American Association of Physicists in Medicine Task Group 263: Standardizing Nomenclatures in Radiation Oncology
- Motion Management Strategies and Technical Issues Associated with Stereotactic Body Radiotherapy of Thoracic and Upper Abdominal Tumors: A Review from NRG Oncology
- High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: treatment description and preliminary results of a phase I/II clinical trial
- Highly efficient training, refinement, and validation of a knowledge-based plan quality control system for radiotherapy clinical trials
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.